Review of “Therapeutic properties of Artemisia annua” by DoorlessCarp

DoorlessCarp, in “Therapeutic properties of Artemisia annua” reviewed a very large amount of literature on Artemisia annua and other Artemisia species and provided convincing evidence that the genus of Artemisia contains multiple species with wide-ranging therapeutic properties applicable to such diseases as cancer, HIV, malaria, and SARS2. 

That is still in draft form and has yet to be published.

It is a sign of the times that a scientific paper may have to be published anonymously.  The medical community lives in fear of losing their jobs for speaking the truth. Sadly, an abstract section in the paper is full of reports that have been censored in traditional media. DoorlessCarp published numerous social media accounts describing cancer, miscarriages, and Sudden Adult Death Syndrome (SADS) as a result of the mRNA-themed poisons that are marketed as “vaccines” to the public. 

I was honored to be mentioned in DoorlessCarp's research paper.  Although my contribution was small on medical theory, it nevertheless represents a major step forward in information sharing and reporting.  The paper includes a section I wrote describing how the World Health Organization and media organizations that do their bidding have actively censored the ability of Artemisa annua to treat SARS2. As an individual whose reporting has been censored, it is good to see research on converge on a censored topic.

The paper represents much more than a potential for the medical use of one herb.

DoorlessCarp's paper supports my believe that the healthcare industry’s “chemotherapy” approach to medicine is seriously flawed.  The industry standard of today is to treat symptoms of disease with chemicals. Because this genus of Artemisia can treat not only multiple viruses, but also cancer, it clearly has some method of helping the body to fight disease in general. The wide range of therapeutic properties seems to me to support the lifetime of research of Dr. Young, who describes virus and cancer as more of a result of disease than a cause. A proper research project of this genus against multiple disease could provide great insight into curing disease in general.

Artemisia absinthium, Artemisia afra, Artemisia arborescens, Artemisia capillaris, Artemisia caruifolia were also reviewed to some extent in the paper. 

The author noted that Artemisia annua was by far the most researched and reviewed species of the genus Artemisia.  The reason for that, in my opinion, is not necessarily because annua is the most therapeutic of the species, but because China has been the world leader in researching ancient herbal recipes. Artemisia annua is native to China.  In China’s research of herbs with medicinal properties, they tend to only test and develop herbs native to China. They do not test herbs native to the rest of the world.  

Chemicals such as Artemisinin and Artemisinin derivatives Artesunate, Aremether, and Dihydroartemisinin were derived from Artemisia annua for commercial distribution by China.  I have seen no evidence that China did a systematic review of all compounds that were in Artemisia annua and selected artemisinin for development based on its therapeutic properties. I have only seen that Artemisinin was isolated by China as result of some chemical process.

A thorough research project of the entire genus of Artemisia is in order.

DoorlessCarp reported that Artemisia afra has therapeutic properties, but is not known to have Artemisinin in it.

For instance, villagers in South Africa began harvesting and selling the species Artemisia afra, native to Africa, in the spring of 2020 for use against SARS2.  Afra, referred to as umhlonyane in South Africa, has been used to treat virus in South Africa since the 1800s. It was used for “Spanish Flu” of 1918.

I myself need to write another article on why I think it is necessary to do a thorough study of the genus Artemisia. I have been informed that Bill Gates has already financed research into Artemisia annua, using genetic modifications to create plants that contain more Artemisinin. I suspect that Gates had the type of study done that I would like to do, that identified and sorted all the compounds in Artemsia annua for therapeutic properties.

There is no telling, of course, what the grim reaper of population control had edited out of his genetically-modified Artemisia annua, or what else he had edited in. I’d like to check his work in an open-sourced manner for the world to see.

Charles Wright